Parkinson's Disease Clinical Trial
Official title:
Effects of Interactive Stepping Exercise on Balance and Cognitive Function in Individuals With Parkinson's Disease
The objective of this study is to investigate the effects of interactive stepping exercise on balance and cognitive function in individuals with PD.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 31, 2021 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Idiopathic PD - Hoehn & Yahr stage between 1 to 3 - Age between 50 to 85 - Stable pharmacologic treatment for the last 2 weeks - Ability to walk 10 meters unassisted or with assistive devices Exclusion Criteria: - Other neurological disorders diagnosis than PD - Receiving any neurological surgeries - Any musculoskeletal disorder or cardiopulmonary disease that may influence participation in the study - The Mini-Mental State Examination (MMSE) < 24 scores - Participated in other exercise intervention of study in the past 3 months - Colorblindness or color vision deficiency |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Yang-Ming University | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Yang Ming University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Romberg test | To evaluate static balance ability | Change from baseline at 8 weeks and 12 weeks | |
Primary | Sharpened Romberg test | To evaluate static balance ability | Change from baseline at 8 weeks and 12 weeks | |
Primary | One-leg stance test | To evaluate static balance ability | Change from baseline at 8 weeks and 12 weeks | |
Primary | Timed up and go test | To evaluate functional walking ability | Change from baseline at 8 weeks and 12 weeks | |
Primary | Mini-Balance Evaluation Systems Test | To evaluate balance ability | Change from baseline at 8 weeks and 12 weeks | |
Primary | Montreal Cognitive Assessment Chinese version | To evaluate global cognitive function | Change from baseline at 8 weeks and 12 weeks | |
Primary | Digit span test | To evaluate executive function | Change from baseline at 8 weeks and 12 weeks | |
Primary | Stroop color and word test Chinese version | To evaluate executive function | Change from baseline at 8 weeks and 12 weeks | |
Primary | Trail-making test Chinese version | To evaluate executive function | Change from baseline at 8 weeks and 12 weeks | |
Primary | Spatial span test | To evaluate visuospatial ability | Change from baseline at 8 weeks and 12 weeks | |
Secondary | 10-meter walk test | To evaluate walking ability | Change from baseline at 8 weeks and 12 weeks | |
Secondary | Parkinson's Disease Questionnaire 39 | To evaluate the quality of life | Change from baseline at 8 weeks and 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |